Lansoprazole filed for NSAID-induced ulcers in Japan
This article was originally published in Scrip
Executive Summary
Takeda has submitted an application in Japan for the approval of Takepron (lansoprazole) for the prevention of gastric and duodenal ulcers associated with the use of non-steroidal anti-inflammatory drugs (NSAIDs).